MAP2K7 and uveal melanoma: Our study highlights several canonical and non-canonical signaling pathways that, when experimentally activated, are capable of modulating sensitivity to MEK and FAK inhibition, outlining a network of potential adaptive signaling responses in uveal melanoma cells.